Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013
Author:
Affiliation:
1. Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
2. Institute of Primary Care and Public Health, School of Medicine, Cardiff University, Cardiff, U.K.
3. Department of Medicine II, Medical University of Vienna, Vienna, Austria
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://diabetesjournals.org/care/article-pdf/36/Supplement_2/S155/483591/s155.pdf
Reference59 articles.
1. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects;Juutilainen;Diabetes Care,2008
2. Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial;Schernthaner;J Clin Endocrinol Metab,2004
3. Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes;Charbonnel;Diabetologia,2005
4. Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study;Russell-Jones;Diabetes Care,2012
5. Efficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: comparison with other oral antihyperglycaemic agents;Derosa;Drugs,2010
Cited by 79 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of 2-deoxy glucose surfaced mixed layer dendrimer: a smart neuron targeted systemic drug delivery system for brain diseases;Theranostics;2024
2. Design, synthesis and anti-hyperglycemic assessments of novel 5-benzylidenethiazolidine-2,4-dione derivatives as PPAR-γ agonist;Journal of the Indian Chemical Society;2023-11
3. Exploring the Relation Between Diabetes and HIV: A Narrative Review;Cureus;2023-08-22
4. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023;Pharmacological Reviews;2023-08-16
5. Pioglitazone and Metformin on Improving Cognitive Dysfunction Caused by Diabetes Mellitus: A Comparative Study;International Journal of Pharmacology;2023-04-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3